Secretory production of recombinant urokinase kringle domain in Pichia pastoris

Journal of Microbiology and Biotechnology

Volumn 13, Issue 4, 2003, Pages 591-597

  Kim, Hyun Kyung ^c   Hong, Yong Kil ^a   Park, Hyo Eun ^c   Hong, Sung Hee ^b   Joe, Young Ae ^c  

^a The Catholic University of Korea   (South Korea)

^b Korea Inst of Radiologial/Med Sci   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Angiogenesis; Inhibitor; Kringle; Pichia pastoris; Urokinase

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; LYSINE; METHANOL; PROTEIN PRECURSOR; RECOMBINANT ENZYME; SERINE; UROKINASE; VASCULOTROPIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME PURIFICATION; ENZYME SYNTHESIS; FUNGUS CULTURE; GENE FUSION; ION EXCHANGE CHROMATOGRAPHY; KRINGLE DOMAIN; MOLECULAR WEIGHT; NONHUMAN; PICHIA PASTORIS; PROTEIN EXPRESSION; PROTEIN SECRETION;

FUNGI; PICHIA; PICHIA PASTORIS;

EID: 0041377638     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Anna-Arriola, S. S. and I. Herskowitz. 1994. Isolation and DNA sequence of the STE13 gene encoding dipeptidyl aminopeptidase. Yeast 10: 801-810.
2. Bachman, F. 1994. Molecular aspects of plasminogen, plasminogen activator, and plasmin, pp. 575-613. In A. L. Bloom, D. P. Thomas, and E. G. D. Tuddenham (eds.), Haemostasis and Thrombosis. Churchill Livingstone, Singapore.
3. Bussey, H. 1988. Proteases and the processing of precursors to secreted proteins in yeast. Yeast 4: 17-26.
4. Cao, Y., R. W. Ji, D. Davidson, J. Schaller, D. Marti, S. Sohndel, S. G. McCance, M. S. O'Reilly, and J. Folkman. 1996. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271: 29461-29467.
5. Castellino, F. J. and J. M. Beals. 1987. The genetic relationships between the kringle domains of human plasminogen, prothrombin, tissue plasminogen activator, urokinase, and coagulation factor XII. J. Mol. Evol. 26: 358-369.
6. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31.
7. Folkman, J. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333: 1757-1763.
8. Folkman, J. 1996. New perspectives in clinical oncology from angiogenesis research. Eur. J. Cancer 32A: 2534-2539.
9. Igarashi, T., K. Miyake, K. Kato, A. Watanabe, M. Ishizaki, K. Ohara, and T. Shimada. 2003. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model. Gene Ther. 10: 219-226.
10. Jaffe, E. A., R. L. Nachman, C. G. Becker, and R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52: 2745-2756.
11. Julius, D., A. Brake, L. Blair, R. Kunisawa, and J. Thorner. 1984. Isolation of the putative stuctural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor. Cell 37: 1075-1089.
12. Julius, D., L. Blair, A. Brake, G. Sprague, and J. Thorner. 1983. Yeast alpha factor is processed from a larger precursor polypeptide: The essential role of a membrane-bound dipeptidyl aminopeptidase. Cell 32: 839-852.
13. Kerbel, R. and J. Folkman. 2002. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2: 727-739.
14. Kim, H. J. and S. Park. 1999. Investigation of hydroxyl radical-induced cross-linking of peptides and its inhibition by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Bull. Korean Chem. Soc. 20: 370-372.
15. Kim, J. M., S. H. Ho, E. J. Park, W. Hahn, H. Cho, J. G. Jeong, Y. W. Lee, and S. Kim. 2002. Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis. Arthritis Rheum. 46: 793-801.
16. Kim, K. S., Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, and S. I. Chung. 2003. Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells. J. Biol. Chem. 278: 11449-11456.
17. Kim, T. R., Y. Goto, N. Hirota, K. Kuwata, H. Denton, S. Y. Wu, L. Sawyer, and C. A. Batt. 1997. High-level expression of bovine beta-lactoglobulin in Pichia pastoris and characterization of its physical properties. Protein Eng. 10: 1339-1345.
18. Kirsch, M., J. Strasser, R. Allende, L. Bello, J. Zhang, and P. M. Black. 1998. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res. 58: 4654-4659.
19. Ko, H. R., H. Kakeya, A. Yoshida, R. Onose, M. Ueki, M. Muroi, A. Takatsuki, H. Matsuzaki, and H. Osada. 2002. PC-766B and PC-766B, 16-membered macrolide angiogenesis inhibitors produced by Nocardia sp. RK97-56. J. Microbiol. Biotechnol. 12: 829-833.
20. Kwon, H. J., D. H. Kim, J. S. Shim, and J. W. Ahn. 2002. Apicularen A, a macrolide from Chondromyces sp., inhibits growth factor induced in vitro angiogenesis. J. Microbiol. Biotechnol. 12: 702-705.
21. Nilsen, S. L., M. E. Deford, M. Prorok, B. A. Chibber, R. K. Bretthauer, and F. J. Castellino. 1997. High-level secretion in Pichia pastoris and biochemical characterization of the recombinant kringle 2 domain of tissue-type plasminogen activator. Biotechnol. Appl. Biochem. 25: 63-74.
22. O'Reilly, M. S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2: 689-692.
23. O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S. Lane, Y. Cao, E. H. Sage, and J. Folkman. 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328.
24. Raisler, B. J., K. I. Berns, M. B. Grant, D. Beliaev, and W. W. Hauswirth. 2002. Adeno-associated virus type-2 expression of pigmented epithelium-derived factor or Kringles 1-3 of angiostatin reduce retinal neovascularization. Proc. Natl. Acad. Sci. USA 99: 8909-8914.
25. Shepard, S. R., R. Boucher, J. Johnston, R. Boerner, G. Koch, J. W. Madsen, D. Grella, B. K. Sim, and J. L. Schrimsher. 2000. Large-scale purification of recombinant human angiostatin. Protein Exper. Purif. 20: 216-227.